InfuSystems Holdings, Inc. (INFU) Social Stream
Featured Post From StockTwits About INFU
$INFU 2021 Second Quarter Overview:StockBraker, published August 12, 2021
Net revenues totaled $24.8 million, a decrease of 4% vs. prior year and up 2% sequentially.
ITS net revenue was $16.3 million, an increase of 5% vs. prior year.
DME Services net revenue was $8.5 million, a decrease of 18% vs. prior year.
Pain Management and Negative Pressure Wound Therapy (“NPWT”) combined net revenues increased $0.7 million or 114% vs. prior year.
Gross profit was $15.1 million, a decrease of 6% vs. prior year and up 3% sequentially.
Gross margin was 60.6%, a decrease of 0.9% vs. prior year and up 1% sequentially.
Net income of $0.8 million, or $0.04 per diluted share.
Adjusted earnings before interest, income taxes, depreciation, and amortization (“Adjusted EBITDA”) (non-GAAP) was $5.9 million, a decrease of 31% vs. prior year.
Net cash provided by operations was $8.8 million, an increase of 107% vs. prior year.
During the six-month period the Company acquired FilAMed and OB Healthcare for a total of $7.5 million.